Rekombinanter Cetuximab Antikörper
MALS verified
Reaktivität: Human
Wirt: Maus
Monoclonal
12B1E9
unconjugated
Recombinant Antibody
-
- Target Alle Cetuximab Produkte
- Cetuximab
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Cetuximab Antikörper ist unkonjugiert
- Verwendungszweck
- Anti-Cetuximab Antibody (12B1E9) (recommended for PK/PD, MALS verified)
- Produktmerkmale
- Anti-idiotypic Antibodies
- Güteklasse
- MALS verified
- Immunogen
- Anti-Cetuximab Antibody (12B1E9) (ABIN7482184) is a monoclonal antibody recombinantly expressed from human 293 cells (HEK293). The mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Cetuximab ADA.
- Klon
- 12B1E9
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Lagerung
- -20 °C
-
- Target
- Cetuximab
- Abstract
- Cetuximab Produkte
- Substanzklasse
- Antibody
- Hintergrund
- Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable, antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions.
-
Sie sind hier:
